February 21, 2007 – InSightec’s ExAblate 2000, a Magnetic Resonance Imaging (MRI) focused ultrasound device that treats uterine fibroid tumors, is now allowing most patients to find relief within three months of treatment and to return to work within days.
The ExAblate 2000 uses a combination of ultrasound waves and MRIs to image, treat and ablate soft tissue. Treatment typically takes about three or four hours.
Nov. 20, 2025 — Avatar Medical and Barco have launched Eonis Vision, marking a new evolution in how medical imaging is ...
November 20, 2025 
Nov. 19, 2025 — Royal Philips has announced an extended partnership with Cortechs.ai. Together, the companies will ...
November 19, 2025 
Once viewed as a solution for after-hours coverage, teleradiology is rapidly expanding into a critical part of radiology ...
November 06, 2025 
Oct. 31, 2025 — Echolight plans to demonstrate its bone density scanning technology at the Radiological Society of North ...
November 03, 2025 
Oct. 24, 2025 —YorLabs, Inc., a medical technology company developing next-generation intracardiac imaging solutions for ...
October 27, 2025 
Oct. 16, 2025 — A strategic collaboration between UC San Diego Health and GE HealthCare will focus on bringing advanced ...
October 20, 2025 
Sept. 30, 2025 — Sona, the first free, HIPAA-compliant platform that securely delivers ultrasound images directly to ...
October 02, 2025 
Sept. 26, 2025 — At the American Society for Radiation Oncology (ASTRO) 2025 annual meeting in San Francisco, Calif ...
September 29, 2025 
Sept. 15, 2025 — GE HealthCare has launched the Voluson Performance series, the latest addition to its women’s health ...
September 15, 2025 
Aug. 29, 2025 — GE HealthCare has launched Vivid Pioneer, its most advanced, ultra-premium and adaptive cardiovascular ...
August 29, 2025 